Search Results - "ØRSKOV, C"

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem by Larsen, P.J, Tang-Christensen, M, Holst, J.J, Ørskov, C

“…Central administration of the preproglucagon-derived peptide glucagon-like peptide-1 significantly inhibits ingestion of food and water, and glucagon-like…”
Get full text

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice by Thulesen, J, Hartmann, B, Hare, K J, Kissow, H, Ørskov, C, Holst, J J, Poulsen, S S

“…Background: Glucagon-like peptide 2 (GLP-2) is an intestinotrophic mediator with therapeutic potential in conditions with compromised intestinal capacity…”
Get full text

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients by NAUCK, M. A, KLEINE, N, ØRSKOV, C, HOLST, J. J, WILLS, B, CREUTZFELDT, W

“…Glucagon-like peptide 1 (GLP-1) (7-36 amide) is a physiological incretin hormone that is released after nutrient intake from the lower gut and stimulates…”
Get full text

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM by NAUCK, M. A, WOLLSCHLÄGER, D, WERNER, J, HOLST, J. J, ØRSKOV, C, CREUTZFELDT, W, WILLMS, B

“…Intravenous glucagon-like peptide (GLP)-1 [7-36 amide] can normalize plasma glucose in non-insulin-dependent diabetic (NIDDM) patients. Since this is no form…”
Get full text

IFNγ and Perforin Cooperate to Control Infection and Prevent Fatal Pathology During Persistent Gammaherpesvirus Infection in Mice by Bartholdy, C., Høgh‐Petersen, M., Storm, P., Holst, P. J., Ørskov, C., Christensen, J. P., Thomsen, A. R.

“…Infection with murine gammaherpesvirus 68 has become an accepted model for studying the virus/host interactions with regard to gammaherpesvirus infections…”
Get full text

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients by Creutzfeldt, W O, Kleine, N, Willms, B, Orskov, C, Holst, J J, Nauck, M A

“…Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. W O Creutzfeldt ,…”
Get full text

Glucagon-like peptide-1, a new hormone of the entero-insular axis by ØRSKOV, C

Get full text

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus by NAUCK, M. A, HEIMESAAT, M. M, ØRSKOV, C, HOLST, J. J, EBERT, R, CREUTZFELDT, W

“…In type-2 diabetes, the overall incretin effect is reduced. The present investigation was designed to compare insulinotropic actions of exogenous incretin…”
Get full text

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans by ØRSKOV, C, RABENHØJ, L, WETTERGREN, A, KOFOD, H, HOLST, J. J

“…Using specific radioimmunoassays, we studied the occurrence of amidated and glycine-extended glucagon-like peptide I (GLP-I) molecules in the human small…”
Get full text

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus by Gutniak, Mark, Ørkov, Cathrine, Holst, Jens J, Ahrén, Bo, Efendić, Suad

“…Glucagon-like peptide-1 (7–36)amide (glucagon-like insulinotropic peptide, or GLIP) is a gastrointestinal peptide that potentiates the release of insulin in…”
Get full text

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations by Nauck, M A, Bartels, E, Orskov, C, Ebert, R, Creutzfeldt, W

“…Gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1-(7-36) amide (GLP-1) are glucose-dependent insulinotropic gut hormones that may explain the…”
Get more information

Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I by ØRSKOV, C, POULSEN, S. S, MØLLER, M, HOLST, J. J

“…The intestinal incretin hormone glucagon-like peptide I (GLP-I) inhibits gastric motility and secretion in normal, but not in vagotomized subjects, pointing to…”
Get full text

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine by ØRSKOV, C, JEPPESEN, J, MADSBAD, S, HOLST, J. J

“…We investigated the major products of proglucagon (PG) processing in plasma in the fasting state, after intravenous arginine and after an oral glucose load in…”
Get full text

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach by Orskov, C, Holst, J J, Nielsen, O V

“…We studied the effect of truncated glucagon-like peptide-1 [naturally occurring GLP-1; proglucagon-(78-107) amide], a potent insulinotropic peptide from the…”
Get more information

GLP-1 does not acutely affect insulin sensitivity in healthy man by ØRSKOV, L, HOLST, J. J, MØLLER, J, ØRSKOV, C, MØLLER, N, ALBERTI, K. G. M. M, SCHMITZ, O

Get full text

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut by Holst, J.J., Ørskov, C., Vagn Nielsen, O., Schwartz, T.W.

“…By hydrophobic gel permeation and high pressure liquid chromatography we isolated from pig intestinal mucosa a peptide which corresponds to proglucagon 78–107…”
Get full text

Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in Type 2 diabetic patients by Nauck, M.A., Weber, I., Bach, I., Richter, S., Ørskov, C., Holst, J.J., Schmiegel, W.

“…Intravenous GLP‐1 [7‐36 amide] can normalize fasting hyperglycaemia in Type 2 diabetic patients. Whether GLP‐1 [7‐37] has similar effects and how quickly…”
Get full text

The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas by DE HEER, J, PEDERSEN, J, ORSKOV, C, HOLST, J. J

“…Glucagon-like peptide-2 (GLP-2) is a gut hormone regulating intestinal growth and nutrient absorption. Recently, GLP-2 has been reported to stimulate glucagon…”
Get full text

Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose) by Qualmann, C, Nauck, M A, Holst, J J, Orskov, C, Creutzfeldt, W

“…After nutrient ingestion there is an early response of glucagon-like peptide 1 (GLP-1) immunoreactivity, although GLP-1 is mainly produced in endocrine cells…”
Get more information

Nitric Oxide Has Tonic Inhibitory Effect, But Is Not Involved in the Vagal Control or VIP Effects on Motility of the Porcine Antrum by SCHMIDT, P. T, ØRSKOV, C, RASMUSSEN, T. N, HOLST, J. J

“…Background: The involvement of nitric oxide (NO) in vagal control and vasoactive intestinal polypeptide (VIP)-induced effects on antral motility was studied…”
Get full text